Levels of neurogranin in Aβ 42/40 ratio subgroups do not aid further in the postulation if the patients suffer from AD since neurogranin could be increased regardless of whether amyloid pathology exists or not among AD patients [33]. This evidence concerns the gene NRGN and Alzheimer disease.